Cytotoxicity News and Research

RSS
Budesonide’s antiviral effect against SARS-CoV-2

Budesonide’s antiviral effect against SARS-CoV-2

Rosin soap as a potential SARS-CoV-2 disinfectant

Rosin soap as a potential SARS-CoV-2 disinfectant

COVID-19 researchers review 184 drug repurposing candidates

COVID-19 researchers review 184 drug repurposing candidates

“React and inject”: synthetic peptide-modified nanodiamonds as emergency pan-coronavirus vaccines

“React and inject”: synthetic peptide-modified nanodiamonds as emergency pan-coronavirus vaccines

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

Mustard seed, wall rocket and turmeric extracts show potential against SARS-CoV-2 in vitro

Mustard seed, wall rocket and turmeric extracts show potential against SARS-CoV-2 in vitro

Cationic peptides inhibit SARS-CoV-2 cell entry

Cationic peptides inhibit SARS-CoV-2 cell entry

Could the activation of FcγRIII/CD16 by anti-spike SARS-CoV-2 antibodies independently determine COVID-19 severity?

Could the activation of FcγRIII/CD16 by anti-spike SARS-CoV-2 antibodies independently determine COVID-19 severity?

Green tea catechins might be useful as pan-coronavirus inhibitors

Green tea catechins might be useful as pan-coronavirus inhibitors

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Study shows activation of CD16+ T-cells contribute to severe COVID-19 illness

Study shows activation of CD16+ T-cells contribute to severe COVID-19 illness

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

The role of natural killer cells in fight against viral infections including SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

Using natural killers from the immune system to target breast cancer cells

Using natural killers from the immune system to target breast cancer cells

New approach could revolutionize treatment, prevention of Parkinson’s disease

New approach could revolutionize treatment, prevention of Parkinson’s disease

NIH researchers identify novel small molecule inhibitors of SARS-CoV-2 variants

NIH researchers identify novel small molecule inhibitors of SARS-CoV-2 variants

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds